Dacomitinib (Standard)
Dacomitinib (Standard) is the analytical standard of Dacomitinib. This product is intended for research and analytical applications. Dacomitinib (PF-00299804) is a specific and irreversible inhibitor of the ERBB family of kinases with IC50s of 6 nM, 45.7 nM and 73.7 nM for EGFR, ERBB2, and ERBB4, respectively.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- Reinheit : 98%
- CAS. Nr.: 1110813-31-4
- Formel: C24H25ClFN5O2
- Molecular Weight:469.94
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Product Information
-
Chemical Information
- Reinheit & Dokumentation
-
Help & FAQs
-
HY-13272
DacomitinibErbB Inhibitor -
HY-15772
OsimertinibMutant-Selective EGFR Inhibitor -
HY-50895
GefitinibEGFR Inhibitor -
HY-50896
ErlotinibEGFR Tyrosine Kinase Inhibitor -
HY-50898
LapatinibEGFR/HER2 Inhibitor -
HY-12000
AG490EGFR Inhibitor -
HY-15772R
Osimertinib (Standard)Mutant-Selective EGFR Inhibitor -
HY-32721
NeratinibHER2/EGFR Inhibitor -
HY-15730
PoziotinibEGFR Inhibitor -
HY-10045
AEE788EGFR/ErbB2 Inhibitor -
HY-13524
AG-1478EGFR Inhibitor -
HY-16558
ButeinEGFR/PDE Inhibitor
Product Information
Information
Anwendung
The compound is the grade of analytical standard, which is the reference standard supplied assay. It is commonly used in qualitative, quantitative and methodological research experiments in HPLC, GC and MS.
Chemical Information
-
CAS. Nr. 1110813-31-4
-
Molecular Weight 469.94
-
Formel C24H25ClFN5O2
-
SMILES
O=C(/C=C/CN1CCCCC1)NC2=CC3=C(C=C2OC)N=CN=C3NC4=CC=C(C(Cl)=C4)F
-
Synonyms
PF-00299804 (Standard); PF-299804 (Standard)
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Reinheit & Dokumentation
Verweise
[1]. Engelman JA, et al. PF00299804, an irreversible pan-ERBB inhibitor, is effective in lung cancer models with EGFR and ERBB2 mutations that are resistant to ZD1839. Cancer Res. 2007 Dec 15;67(24):11924-32. [Content Brief]
[2]. Kalous O, et al. Dacomitinib (PF-00299804), an irreversible Pan-HER inhibitor, inhibits proliferation of HER2-amplified breast cancer cell lines resistant to Anti-Human HER2 and GW572016. Mol Cancer Ther. 2012 Sep;11(9):1978-87. [Content Brief]
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)
Dacomitinib (Standard) Related Classifications
HY-13272R Related Classifications
Powered by Bioz